Abstract
Mouse peritoneal macrophages (MPM) cultivated with a mouse beta-interferon preparation (MuIFN-β or "mock" IFN were tested for phagocytic ability and intracellular levels of adenosine 3′,5′-cyclic monophosphate (cAMP). Suspensions of nonopsonized Escherichia coli (E. coli) were used for phagocytosis experiments. Treatment of MPM with 101–103 U per ml of MuIFN-β stimulated the phagocytic activity and raised the levels of cAMP in MPM. The effect of MuIFN-β on cAMP levels were dose and time dependent. Maximal cAMP levels were seen when MPM were incubated with 103–104 U per ml of MuIFN-β for five hours. Simultaneous addition of MuIFN-β and the adenylcyclase inhibitor N-etylmaleimide to the MPM cultures prevented the rise in cAMP levels but not the increased phagocytic capacity. MuIFN-β induced enhancement of phagocytosis and elevation of cAMP levels in MPM seem to be two parallel but not interlinked processes.
Get full access to this article
View all access options for this article.
